NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1770533788 MD
Verify on CMS → Robert Burr, MD
Endocrinology, Diabetes & Metabolism Physician in Lebanon, New Hampshire.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
954
Medicare Part D claims · 206 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
17%
generic claims · 76% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$403.14
20 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Robert Burr, MD filed 954 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Lebanon, New Hampshire, prescribing 17% generic.
- 954
- Part D claims, 2024
- 17%
- generic prescribing
- $403.14
- industry payments (Sunshine Act)
- ≥74th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Robert Burr, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1770533788), first enumerated 05/11/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 954 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$403.14 in reported industry payments (20 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1770533788 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1770533788
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- RX-LIGHT 954
- BOOK-THIN 59 in New Hampshire
- PHOTO-ENUM Myron Miller · 2006
Robert Burr, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
954 ≥ 74th percentile 74% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Robert Burr, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Robert Burr, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
954 65% vs specialty avg
Specialty distribution in New Hampshire
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Hampshire providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1770533788 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/11/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Robert Burr, MD. Source: openpaymentsdata.cms.gov.
Total received
$403
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Robert Burr, MD - brand share 76.0%
Endocrinology, Diabetes & Metabolism Physician average
76% brand-name claims vs 17% generic, on 954 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
954
Total Claims
$756K
Total Drug Cost
206
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,621.5
- Total Day Supply
- 47,278
- Brand vs Generic
- 76% brand / 17% generic
- Brand Drug Cost
- $740K
- Generic Drug Cost
- $6K
Patient Demographics
- Average Patient Age
- 68.5 years
- Avg HCC Risk Score
- 1.58
- Gender Split
- 51% female / 49% male
- Age Distribution
- <65: 49, 65-74: 106, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Robert Burr, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Mounjaro
Mounjaro
136 claims
- Jardiance
Jardiance
126 claims
- Ozempic
Ozempic
66 claims
- Trulicity
Trulicity
59 claims
- Tresiba Flextouch …
Tresiba Flextouch U-200
58 claims
- Metformin Hcl Er 51
Metformin Hcl Er
51 claims
- Tresiba Flextouch … 39
Tresiba Flextouch U-100
39 claims
- Lantus Solostar 35
Lantus Solostar
35 claims
| Drug | Claims |
|---|---|
| Mounjaro Tirzepatide | 136 |
| Jardiance Empagliflozin | 126 |
| Ozempic Semaglutide | 66 |
| Trulicity Dulaglutide | 59 |
| Tresiba Flextouch U-200 Insulin Degludec | 58 |
| Metformin Hcl Er Metformin Hcl | 51 |
| Tresiba Flextouch U-100 Insulin Degludec | 39 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 35 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 35 |
| Levothyroxine Sodium | 30 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in NH →
All providers in New Hampshire →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Robert Burr, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Robert Burr, MD's 954 claims are below the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Burr, both outside New Hampshire so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Hampshire
Other clinicians with the same primary specialty enrolled in New Hampshire, drawn from the same CMS NPPES roster as Burr.
One of 59 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New Hampshire, 5 are shown here.
Dr. Stephanie Barry
MD
Dover, NH
Dr. Paul Beisswenger
M.D.
Lebanon, NH
Dr. Kathleen Belbruno
MD
Lebanon, NH
Dr. Jenny Bello Ramos
MD
Manchester, NH
Dr. Benjamin Boh
D.O.
Lebanon, NH
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Robert Burr, MD's specialty? ▼
Robert Burr, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Lebanon, New Hampshire. Credentials: MD.
How much does Robert Burr, MD prescribe under Medicare Part D? ▼
In 2024, Robert Burr, MD wrote 954 Medicare Part D claims totaling $756K in drug costs for 206 beneficiaries.
Where is Robert Burr, MD located? ▼
Robert Burr, MD is located at 1 MEDICAL CENTER DR, Lebanon, NH, 03756. Phone: (603) 650-5000.
What is Robert Burr, MD's NPI number? ▼
Robert Burr, MD's National Provider Identifier (NPI) is 1770533788, issued on 05/11/2006.
Does Robert Burr, MD prescribe more brand-name or generic drugs? ▼
Robert Burr, MD's prescribing is 76% brand-name and 17% generic drugs by claim count, with $740K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Robert Burr, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Robert Burr, MD's most frequently prescribed drugs include Mounjaro, Jardiance, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Robert Burr, MD accept Medicare? ▼
Robert Burr, MD appears in CMS Medicare data with 954 Part D claims and 206 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Robert Burr, MD's credentials? ▼
Robert Burr, MD's NPI is 1770533788 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.